慢性乙型肝炎-话题@MedSci

#慢性乙型肝炎#

119篇内容 | 4246人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271314, encodeId=416812e131460, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=慢性乙型肝炎相关肝癌风险预测模型全面总结, objectType=article, longId=215279, objectId=425f2152e99a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=425f2152e99a, replyNumber=0, likeNumber=90, createdTime=2021-08-05, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=425f2152e99a, moduleTitle=慢性乙型肝炎相关肝癌风险预测模型全面总结, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=425f2152e99a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271313, encodeId=526012e131324, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, objectType=article, longId=214297, objectId=744721429ee4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744721429ee4, replyNumber=0, likeNumber=88, createdTime=2021-07-17, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744721429ee4, moduleTitle=AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744721429ee4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271312, encodeId=b13712e1312bb, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, objectType=article, longId=209258, objectId=9b01209258ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b01209258ab, replyNumber=0, likeNumber=72, createdTime=2021-04-01, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b01209258ab, moduleTitle=Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b01209258ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271311, encodeId=7ce612e1311f8, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Dig Dis Sci：粪便微生物群移植在清除慢性乙型肝炎患者体内乙肝表面抗原中的作用, objectType=article, longId=208401, objectId=0da7208401c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0da7208401c8, replyNumber=0, likeNumber=80, createdTime=2021-03-16, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0da7208401c8, moduleTitle=Dig Dis Sci：粪便微生物群移植在清除慢性乙型肝炎患者体内乙肝表面抗原中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0da7208401c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271310, encodeId=2b7b12e13107d, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关, objectType=article, longId=207199, objectId=582320e199b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=582320e199b9, replyNumber=0, likeNumber=90, createdTime=2021-02-18, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=582320e199b9, moduleTitle=Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=582320e199b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271309, encodeId=2d6412e1309f8, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, objectType=article, longId=206053, objectId=87a720605372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87a720605372, replyNumber=0, likeNumber=104, createdTime=2021-01-24, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87a720605372, moduleTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87a720605372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271308, encodeId=b3d512e1308b2, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, objectType=article, longId=205090, objectId=009e20509087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=009e20509087, replyNumber=0, likeNumber=85, createdTime=2021-01-02, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=009e20509087, moduleTitle=新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=009e20509087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271307, encodeId=570612e1307d4, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异, objectType=article, longId=203042, objectId=810d20304236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810d20304236, replyNumber=0, likeNumber=89, createdTime=2020-11-09, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810d20304236, moduleTitle=Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810d20304236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271306, encodeId=e24112e1306a4, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低, objectType=article, longId=201012, objectId=e8152010122f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8152010122f, replyNumber=0, likeNumber=62, createdTime=2020-09-23, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8152010122f, moduleTitle=AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8152010122f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271305, encodeId=d74812e13059e, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险, objectType=article, longId=197274, objectId=7a2819e27474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a2819e27474, replyNumber=0, likeNumber=69, createdTime=2020-07-11, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a2819e27474, moduleTitle=Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a2819e27474)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271304, encodeId=488612e130484, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, objectType=article, longId=197180, objectId=5d3919e180a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d3919e180a1, replyNumber=0, likeNumber=68, createdTime=2020-07-09, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d3919e180a1, moduleTitle=AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d3919e180a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271303, encodeId=f1af12e1303df, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加, objectType=article, longId=197150, objectId=f49919e1509f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f49919e1509f, replyNumber=0, likeNumber=105, createdTime=2020-07-08, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f49919e1509f, moduleTitle=AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f49919e1509f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271302, encodeId=487712e1302c7, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关, objectType=article, longId=192144, objectId=eefa19214401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eefa19214401, replyNumber=0, likeNumber=67, createdTime=2020-04-14, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eefa19214401, moduleTitle=Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eefa19214401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271301, encodeId=335812e13012c, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后, objectType=article, longId=191009, objectId=8ee1191009e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ee1191009e3, replyNumber=0, likeNumber=85, createdTime=2020-03-29, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ee1191009e3, moduleTitle=JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ee1191009e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271300, encodeId=42be12e13007c, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AJG：抗病毒治疗期间较早的丙氨酸氨基转移酶正常化与慢性乙型肝炎肝细胞癌的低风险独立相关, objectType=article, longId=186863, objectId=55171868635b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55171868635b, replyNumber=0, likeNumber=77, createdTime=2020-01-29, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55171868635b, moduleTitle=AJG：抗病毒治疗期间较早的丙氨酸氨基转移酶正常化与慢性乙型肝炎肝细胞癌的低风险独立相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55171868635b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271299, encodeId=22b312e1299cf, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Clinical Translational Gastroenterology：性别和生殖因素对慢性乙型肝炎患者肝纤维化的影响, objectType=article, longId=184576, objectId=072f1845e6a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=072f1845e6a0, replyNumber=0, likeNumber=86, createdTime=2019-12-13, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=072f1845e6a0, moduleTitle=Clinical Translational Gastroenterology：性别和生殖因素对慢性乙型肝炎患者肝纤维化的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=072f1845e6a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271298, encodeId=8aa412e1298a8, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生, objectType=article, longId=183120, objectId=cf0b18312019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf0b18312019, replyNumber=0, likeNumber=74, createdTime=2019-11-19, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf0b18312019, moduleTitle=吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf0b18312019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271297, encodeId=7e8b12e129723, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=AP&T：替诺福韦可减少慢性乙型肝炎肝硬化患者的肝细胞癌发生率及相关死亡风险, objectType=article, longId=180582, objectId=06e71805822e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06e71805822e, replyNumber=0, likeNumber=105, createdTime=2019-10-07, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06e71805822e, moduleTitle=AP&T：替诺福韦可减少慢性乙型肝炎肝硬化患者的肝细胞癌发生率及相关死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06e71805822e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271296, encodeId=c3a112e1296ac, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析, objectType=article, longId=179352, objectId=ef901e935215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef901e935215, replyNumber=0, likeNumber=76, createdTime=2019-09-14, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef901e935215, moduleTitle=J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef901e935215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271295, encodeId=0f2c12e129583, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=慢性乙型肝炎临床治愈(功能性治愈)专家共识2019, objectType=article, longId=178201, objectId=175f1e820131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=175f1e820131, replyNumber=0, likeNumber=68, createdTime=2019-08-27, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=175f1e820131, moduleTitle=慢性乙型肝炎临床治愈(功能性治愈)专家共识2019, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=175f1e820131)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性乙型肝炎

2020-05-29

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

慢性乙型肝炎相关肝癌风险预测模型全面总结

2021-08-05

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AP&T: 慢性乙型肝炎抗病毒治疗患者中心性肥胖与肝细胞癌的关系

2021-07-17

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Clin Translational Gastroenterology:阿司匹林可以减少接受口服核苷类似物的慢性乙型肝炎患者的肝细胞癌发病率

2021-04-01

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Dig Dis Sci：粪便微生物群移植在清除慢性乙型肝炎患者体内乙肝表面抗原中的作用

2021-03-16

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Dig Dis Sci:慢性乙型肝炎患者晚期肝纤维化与坏死性炎症相关与肝脂肪变性无关

2021-02-18

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况

2021-01-24

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

新型免疫疗法HepTcel治疗慢性乙型肝炎，即将开展国际多中心研究

2021-01-02

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Clin Gastroenterology H：恩替卡韦与替诺福韦治疗慢性乙型肝炎病毒感染的肝细胞癌发生率方面无差异

2020-11-09

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AP&T: ALT水平低的慢性乙型肝炎患者发生重大肝脏炎症的可能性非常低

2020-09-23

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Hepatology:慢性乙型肝炎患者使用他汀类药物可降低肝细胞癌的风险

2020-07-11

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AP&T:免疫耐受期慢性乙型肝炎患者发生肝细胞癌的风险极低

2020-07-09

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AP&T:慢性乙型肝炎患者队列中的疾病合并症随时间增加

2020-07-08

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Clinica Chimica Acta：白蛋白-胆红素评分与慢性乙型肝炎患者对聚乙二醇化干扰素和核苷类似物的反应有关

2020-04-14

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

JVH：HBV pgRNA能够预测NAs抗病毒治疗慢性乙型肝炎患者的长期预后

2020-03-29

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AJG：抗病毒治疗期间较早的丙氨酸氨基转移酶正常化与慢性乙型肝炎肝细胞癌的低风险独立相关

2020-01-29

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Clinical Translational Gastroenterology：性别和生殖因素对慢性乙型肝炎患者肝纤维化的影响

2019-12-13

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

吉利德的Vemlidy在III期研究中，可显著降低慢性乙型肝炎感染患者肝细胞癌的发生

2019-11-19

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

AP&T：替诺福韦可减少慢性乙型肝炎肝硬化患者的肝细胞癌发生率及相关死亡风险

2019-10-07

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Hepatology：恩替卡韦与替诺福韦治疗慢性乙型肝炎的疗效分析

2019-09-14

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

慢性乙型肝炎临床治愈(功能性治愈)专家共识2019

2019-08-27

科室
- - 订阅+
  - 更多科室
工具
服务